|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$74,356.66 |
2.22% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$72,917.25 |
2.18% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$72,250.29 |
2.16% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$72,132.50 |
2.15% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$72,014.25 |
2.15% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$71,196.22 |
2.13% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$71,411.59 |
2.13% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$70,924.44 |
2.12% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$71,053.87 |
2.12% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$71,086.55 |
2.12% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$71,015.93 |
2.12% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$70,959.84 |
2.12% |
| Waters Corporation |
WAT |
941848103 |
147 |
$70,570.29 |
2.11% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$70,210.53 |
2.10% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$70,463.01 |
2.10% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$70,286.74 |
2.10% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$69,895.53 |
2.09% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$69,983.46 |
2.09% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$69,810.78 |
2.08% |
| Steris Plc |
STE |
G8473T100 |
298 |
$69,177.72 |
2.07% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$68,862.08 |
2.06% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$69,022.32 |
2.06% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$69,129.43 |
2.06% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$68,961.18 |
2.06% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$69,106.67 |
2.06% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$68,798.70 |
2.05% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,512.48 |
2.05% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$68,790.46 |
2.05% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$68,363.79 |
2.04% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$68,378.01 |
2.04% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$68,454.87 |
2.04% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$68,323.72 |
2.04% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$67,931.25 |
2.03% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$68,006.25 |
2.03% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$67,762.76 |
2.02% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$67,619.11 |
2.02% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$67,270.00 |
2.01% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$67,133.94 |
2.00% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$66,899.29 |
2.00% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$66,370.26 |
1.98% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$65,685.39 |
1.96% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,394.00 |
1.92% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$63,906.93 |
1.91% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$63,800.68 |
1.91% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$61,734.50 |
1.84% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$60,746.80 |
1.81% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$57,895.07 |
1.73% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$56,452.08 |
1.69% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,541.17 |
1.33% |
| US Dollar |
$USD |
|
24,433 |
$24,433.37 |
0.73% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|